KALA BIO, Inc.
KALA
$3.75
$0.030.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.20M | 4.40M | 4.32M | 5.42M | 4.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.46M | 9.57M | 9.63M | 11.77M | 9.34M |
| Operating Income | -9.46M | -9.57M | -9.63M | -11.77M | -9.34M |
| Income Before Tax | -8.18M | -8.95M | -9.58M | -11.81M | -8.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.18M | -8.95M | -9.58M | -11.81M | -8.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.18M | -8.95M | -9.58M | -11.81M | -8.63M |
| EBIT | -9.46M | -9.57M | -9.63M | -11.77M | -9.34M |
| EBITDA | -9.39M | -9.51M | -9.57M | -11.71M | -9.27M |
| EPS Basic | -1.74 | -1.93 | -3.16 | -4.20 | -3.18 |
| Normalized Basic EPS | -1.09 | -1.15 | -1.98 | -2.59 | -1.14 |
| EPS Diluted | -1.74 | -1.93 | -3.16 | -4.20 | -3.18 |
| Normalized Diluted EPS | -1.09 | -1.15 | -1.98 | -2.59 | -1.14 |
| Average Basic Shares Outstanding | 4.69M | 4.63M | 3.03M | 2.81M | 2.71M |
| Average Diluted Shares Outstanding | 4.69M | 4.63M | 3.03M | 2.81M | 2.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |